+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Topical Drug Delivery Market by Product, Rout to Administration, End-User - Global Forecast 2025-2030- Product Image
Topical Drug Delivery Market by Product, Rout to Administration, End-User - Global Forecast 2025-2030- Product Image
Sale

Topical Drug Delivery Market by Product, Rout to Administration, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4829843
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Topical Drug Delivery Market grew from USD 114.96 billion in 2023 to USD 122.73 billion in 2024. It is expected to continue growing at a CAGR of 6.85%, reaching USD 182.85 billion by 2030.

Topical drug delivery involves administering medication directly onto the skin or mucous membranes to treat localized conditions, offering advantages like reducing systemic side effects. The necessity of topical drug delivery is underscored by its application across numerous therapeutic areas, including dermatology (for conditions such as psoriasis and eczema), pain management, and ophthalmology, where it enables targeted treatment with enhanced patient compliance. End-use segments predominantly include hospitals, clinics, and home care settings. Key insights highlight that demand is driven by a growing incidence of skin conditions, rising geriatric population, and advancements in drug formulation technologies. The market is further buoyed by the trend of self-administration and patient-centric care, where ease of use and reduced administration complexity of topically applied drugs are critical. Emerging opportunities are linked to the development of novel formulations incorporating nanotechnology and microneedle technology to enhance drug penetration and efficacy. Biologic drugs for topical application also present untapped potential, offering personalized medicine avenues. However, the market faces challenges such as variability in drug absorption among different individuals and conditions, potential for irritation or allergic reactions, and stringent regulatory hurdles that may delay product approvals. To mitigate these challenges, ongoing innovation in drug penetration enhancers, formulation stability, and the use of biocompatible materials is essential. The market thrives on cutthroat competition, necessitating strategic collaboration between pharmaceutical companies and technology startups to foster research and development. Areas of innovation include smart drug delivery systems and biosensors that monitor and control dosing in real-time. With the competitive nature of the market, successful navigation involves understanding regional regulatory demands and investing in patient education to enhance adoption rates.

Understanding Market Dynamics in the Topical Drug Delivery Market

The Topical Drug Delivery Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • High prevalence of skin and eye diseases and incidence of burn injuries
    • Preference for transdermal drug delivery
    • Need for medical self-administration and home care
  • Market Restraints
    • Preference for alternative modes of drug delivery
  • Market Opportunities
    • Funding and investments for drug delivery advancements
    • Development of improved targeted delivery of therapeutics
  • Market Challenges
    • Technical barriers related to skin irritation and permeability
    • Drug failures and product recalls

Exploring Porter’s Five Forces for the Topical Drug Delivery Market

Porter’s Five Forces framework further strengthens the insights of the Topical Drug Delivery Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Topical Drug Delivery Market

External macro-environmental factors deeply influence the performance of the Topical Drug Delivery Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Topical Drug Delivery Market

The Topical Drug Delivery Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Topical Drug Delivery Market

The Topical Drug Delivery Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Topical Drug Delivery Market

The Topical Drug Delivery Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Topical Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Absorption Systems LLC, Bayer AG, Cipla Limited, Custom Converting, Inc., Galderma Laboratories, L.P., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Services, Inc., MedPharm Ltd., Mylan N.V., Novartis AG, Novartis International AG, Pfizer Inc., and The Lubrizol Corporation.

Market Segmentation & Coverage

This research report categorizes the Topical Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Liquid Formulations
      • Solutions
      • Suspensions
    • Semi-Solid Formulations
      • Creams
      • Gels
      • Lotions
      • Ointments
      • Pastes
    • Solid Formulations
      • Powders
      • Suppositories
    • Transdermal Products
      • Transdermal Patches
      • Transdermal Semi-Solids
  • Rout to Administration
    • Dermal Drug Delivery
    • Nasal Drug Delivery
    • Ophthalmic Drug Delivery
    • Rectal Drug Delivery
    • Vaginal Drug Delivery
  • End-User
    • Burn Centers
    • Home Care Settings
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of skin and eye diseases and incidence of burn injuries
5.1.1.2. Preference for transdermal drug delivery
5.1.1.3. Need for medical self-administration and home care
5.1.2. Restraints
5.1.2.1. Preference for alternative modes of drug delivery
5.1.3. Opportunities
5.1.3.1. Funding and investments for drug delivery advancements
5.1.3.2. Development of improved targeted delivery of therapeutics
5.1.4. Challenges
5.1.4.1. Technical barriers related to skin irritation and permeability
5.1.4.2. Drug failures and product recalls
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Topical Drug Delivery Market, by Product
6.1. Introduction
6.2. Liquid Formulations
6.2.1. Solutions
6.2.2. Suspensions
6.3. Semi-Solid Formulations
6.3.1. Creams
6.3.2. Gels
6.3.3. Lotions
6.3.4. Ointments
6.3.5. Pastes
6.4. Solid Formulations
6.4.1. Powders
6.4.2. Suppositories
6.5. Transdermal Products
6.5.1. Transdermal Patches
6.5.2. Transdermal Semi-Solids
7. Topical Drug Delivery Market, by Rout to Administration
7.1. Introduction
7.2. Dermal Drug Delivery
7.3. Nasal Drug Delivery
7.4. Ophthalmic Drug Delivery
7.5. Rectal Drug Delivery
7.6. Vaginal Drug Delivery
8. Topical Drug Delivery Market, by End-User
8.1. Introduction
8.2. Burn Centers
8.3. Home Care Settings
8.4. Hospitals & Clinics
9. Americas Topical Drug Delivery Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Topical Drug Delivery Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Topical Drug Delivery Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. TOPICAL DRUG DELIVERY MARKET RESEARCH PROCESS
FIGURE 2. TOPICAL DRUG DELIVERY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. TOPICAL DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. TOPICAL DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. TOPICAL DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. TOPICAL DRUG DELIVERY MARKET DYNAMICS
TABLE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PASTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUPPOSITORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL SEMI-SOLIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RECTAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY VAGINAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY BURN CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 61. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 62. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 63. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 64. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 98. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 99. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 100. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 101. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 105. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 106. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 107. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 108. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 119. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 120. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 121. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 122. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 161. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 162. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 163. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 164. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 181. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 183. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 184. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 185. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 186. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 190. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 191. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 192. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 193. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 197. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 198. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 199. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 200. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 201. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 204. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 205. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 206. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 207. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 211. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 212. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 213. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 214. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 222. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 225. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 226. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 227. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 228. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 244. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 246. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 247. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 248. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 249. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 253. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 254. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 255. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 256. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 257. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 258. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 260. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 261. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 262. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 263. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 264. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 286. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 287. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 288. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 289. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 290. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 291. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 292. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 306. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 307. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 308. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 309. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 310. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 311. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 312. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 313. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
TABLE 326. UNITED KINGDOM

Companies Mentioned

The leading players in the Topical Drug Delivery Market, which are profiled in this report, include:
  • Absorption Systems LLC
  • Bayer AG
  • Cipla Limited
  • Custom Converting, Inc.
  • Galderma Laboratories, L.P.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson Services, Inc.
  • MedPharm Ltd.
  • Mylan N.V.
  • Novartis AG
  • Novartis International AG
  • Pfizer Inc.
  • The Lubrizol Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 122.73 Billion
Forecasted Market Value ( USD ) by 2030 $ 182.85 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Topical Drugs Market by Product, End-use - Global Forecast 2025-2030 - Product Image

Topical Drugs Market by Product, End-use - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Topical Drug Delivery Global Market Report 2024 - Product Image

Topical Drug Delivery Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Topical Drug Delivery Market Market By Product, By Route Of Administration, Regional Outlook - Global Forecast up to 2030 - Product Image

Topical Drug Delivery Market Market By Product, By Route Of Administration, Regional Outlook - Global Forecast up to 2030

  • Report
  • 116 Pages
  • Global
From
Topical Drug Delivery - Global Strategic Business Report - Product Image

Topical Drug Delivery - Global Strategic Business Report

  • Report
  • 94 Pages
  • Global
From
Topical Drugs Contract Development and Manufacturing Organization (CDMO) Global Market Report 2024 - Product Image

Topical Drugs Contract Development and Manufacturing Organization (CDMO) Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From

About the Topical Drug Delivery Market

The Topical Drug Delivery market is a subset of the larger Drug Delivery market, which focuses on the delivery of drugs to the body through various methods. Topical Drug Delivery involves the application of drugs to the skin, mucous membranes, or other external surfaces of the body. This method of drug delivery is advantageous because it allows for localized delivery of drugs, which can reduce systemic side effects and improve patient compliance. Additionally, topical drug delivery can be used to deliver drugs to specific areas of the body, such as the eyes, ears, and nose. The Topical Drug Delivery market is composed of a variety of companies, including Galderma, Mylan, and Perrigo. These companies specialize in the development and manufacture of topical drug delivery systems, such as creams, ointments, gels, and patches. Additionally, many of these companies offer services such as formulation development, clinical trial support, and regulatory affairs. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.